UBS AM’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-113,601
| Closed | -$119K | – | 2520 |
|
|
2023
Q4 | $119K | Hold |
113,601
| – | – | ﹤0.01% | 2520 |
|
|
2023
Q3 | $778K | Buy |
113,601
+25,585
| +29% | +$175K | ﹤0.01% | 2092 |
|
|
2023
Q2 | $712K | Hold |
88,016
| – | – | ﹤0.01% | 2162 |
|
|
2023
Q1 | $712K | Hold |
88,016
| – | – | ﹤0.01% | 2162 |
|
|
2022
Q4 | $1.39M | Buy |
88,016
+1,310
| +2% | +$20.6K | ﹤0.01% | 1700 |
|
|
2022
Q3 | $1.36M | Buy |
86,706
+439
| +0.5% | +$6.91K | ﹤0.01% | 1792 |
|
|
2022
Q2 | $1.2M | Buy |
86,267
+36,921
| +75% | +$515K | ﹤0.01% | 1859 |
|
|
2022
Q1 | $851K | Hold |
49,346
| – | – | ﹤0.01% | 2224 |
|
|
2021
Q4 | $717K | Buy |
49,346
+12,880
| +35% | +$187K | ﹤0.01% | 2381 |
|
|
2021
Q3 | $656K | Buy |
36,466
+5,186
| +17% | +$93.3K | ﹤0.01% | 2374 |
|
|
2021
Q2 | $549K | Buy |
+31,280
| New | +$549K | ﹤0.01% | 2502 |
|
|
2019
Q2 | – | Sell |
-11,368
| Closed | -$68.1K | – | 2856 |
|
|
2019
Q1 | $68.1K | Buy |
+11,368
| New | +$68.1K | ﹤0.01% | 2592 |
|
|
2018
Q1 | – | Sell |
-9,568
| Closed | -$236K | – | 2654 |
|
|
2017
Q4 | $236K | Sell |
9,568
-224,028
| -96% | -$5.52M | ﹤0.01% | 2227 |
|
|
2017
Q3 | $6.03M | Buy |
233,596
+123,559
| +112% | +$3.19M | 0.01% | 1027 |
|
|
2017
Q2 | $2.98M | Buy |
+110,037
| New | +$2.98M | ﹤0.01% | 1215 |
|